NaviCap™ Targeted Oral Delivery Platform
Treatment at the site of disease in the GI tract could improve outcomes for patients with inflammatory bowel disease
Open letter to Biora Therapeutics shareholders
Read nowTreatment at the site of disease in the GI tract could improve outcomes for patients with inflammatory bowel disease
Needle-free, oral delivery of large molecules designed to replace injection for better management of chronic diseases.
Connect with us